Related Experiment Video
Updated: Sep 17, 2025

09:47
Author Spotlight: Advancing Alzheimer's Research – Exploring Early Detection and Multi-Omics Approaches
Published on: December 15, 2023
1.3K
A comprehensive hybrid model: Combining bioinspired optimization and deep learning for Alzheimer's disease
Chitradevi Dakshinamoorthy1, Prabha S2, Sandeep Kumar Mathivanan3
1Department of Computer Science and Engineering, SRM Institute of Science and Technology, Tiruchirappalli, Tamil Nadu, India, Chennai.
Computers in Biology and Medicine
|June 28, 2025
Summary
This study introduces a novel hybrid optimization technique for Alzheimer's disease (AD) diagnosis. Combining Gray Wolf Optimization (GWO) and Harris Hawk Optimization (HHO) improves brain region segmentation and classification accuracy.
Area of Science:
- Neuroscience
- Medical Imaging
- Computational Intelligence
Background:
- Alzheimer's disease (AD) is a progressive neurodegenerative disorder causing cognitive decline.
- Accurate diagnosis and monitoring of AD are crucial for effective patient care and treatment decisions.
- Current diagnostic methods can be enhanced by advanced image segmentation and classification techniques.
Purpose of the Study:
- To develop and evaluate a novel bioinspired hybrid optimization technique for segmenting brain subregions relevant to AD diagnosis.
- To improve the accuracy of identifying Alzheimer's disease biomarkers through enhanced image segmentation.
- To integrate segmentation with deep learning for accurate classification of AD patients and normal controls.
Main Methods:
- A hybrid approach combining Gray Wolf Optimization (GWO) and Harris Hawk Optimization (HHO) for brain region segmentation.
- Concurrent subpopulation position updates within the GWO and HHO frameworks to refine segmentation.
- Application of deep learning (DL) techniques for classifying normal controls (NC) and AD patients post-segmentation.
- Validation of segmentation accuracy using statistical measures against ground truth (GT).
Main Results:
- The hybrid GWO-HHO technique achieved a segmentation accuracy of 92%.
- The proposed hybrid method demonstrated superior performance compared to HHO alone.
- Deep learning classification achieved 90% accuracy in distinguishing between NC and AD.
- Clinical validation using the Mini Mental State Examination (MMSE) supported disease progression monitoring.
Conclusions:
- The hybrid GWO-HHO technique offers a significant advancement in segmenting brain regions for AD diagnosis.
- The integrated approach of segmentation and deep learning classification shows high accuracy for AD detection.
- This method provides valuable support for clinicians in monitoring AD progression and making treatment decisions.
Related Concept Videos
Alzheimer's Disease: Treatment
265
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
265
Alzheimer's Disease: Overview
678
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
678

